A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults

RJ Valuck, JM Ruscin - Journal of clinical epidemiology, 2004 - Elsevier
OBJECTIVE: Acid-suppressant drugs are commonly prescribed for elderly patients, a population
in which vitamin B 12 deficiency is a common disorder. The purpose of this study was to …

Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs

…, HD Orton, R Allen, RJ Valuck - American Journal of …, 2007 - Am Psychiatric Assoc
Objective: In October 2003, the US Food and Drug Administration (FDA) issued a public
health advisory about the risk of suicidality in pediatric patients taking selective serotonin …

Persisting decline in depression treatment after FDA warnings

AM Libby, HD Orton, RJ Valuck - Archives of general psychiatry, 2009 - jamanetwork.com
Context In October 2003 the Food and Drug Administration (FDA) issued a Public Health
Advisory about the risk of suicidality for pediatric patients taking antidepressants; a boxed …

Metabolic testing rates in 3 state Medicaid programs after FDA warnings and ADA/APA recommendations for second-generation antipsychotic drugs

…, B Druss, DM Hartung, RJ Valuck… - Archives of general …, 2010 - jamanetwork.com
Context In 2003, the Food and Drug Administration (FDA) required a warning on diabetes
risk for second-generation antipsychotic (SGA) drugs. The American Diabetes Association (…

Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study

…, SJ Billups, GJ Okano, RJ Valuck… - … : The Journal of …, 2000 - Wiley Online Library
We examined the impact of ambulatory care clinical pharmacist interventions on clinical and
economic outcomes of 208 patients with dyslipidemia and 229 controls treated at nine …

A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions

PW Sullivan, R Valuck, J Saseen, HM MacFall - CNS drugs, 2004 - Springer
Background: The economic burden of depression is known to be high and was estimated to
be $US83.1 billion in 2000. Serotonin reuptake inhibitors (SRIs), including both selective …

An electronic practice-based network for observational comparative effectiveness research

WD Pace, M Cifuentes, RJ Valuck… - Annals of internal …, 2009 - acpjournals.org
The Distributed Ambulatory Research in Therapeutics Network (DARTNet) is a federated
network of electronic health data from 8 organizations representing more than 500 clinicians …

Multiple sclerosis prevalence in the United States commercially insured population

P Dilokthornsakul, RJ Valuck, KV Nair, JR Corboy… - Neurology, 2016 - AAN Enterprises
Objective: To estimate the US commercially insured multiple sclerosis (MS) annual prevalence
from 2008 to 2012. Methods: The study was a retrospective analysis using PharMetrics …

Antidepressant treatment and risk of suicide attempt by adolescents with major depressive disorder: a propensity-adjusted retrospective cohort study

RJ Valuck, AM Libby, MR Sills, AA Giese, RR Allen - CNS drugs, 2004 - Springer
Context: The US FDA has issued an advisory warning of a possible link between
antidepressant treatment for paediatric patients with major depressive disorder (MDD) and an …

Factors predicting development of opioid use disorders among individuals who receive an initial opioid prescription: mathematical modeling using a database of …

…, J Van Den Bos, D Perlman, J Torres, R Valuck… - Drug and alcohol …, 2014 - Elsevier
… As a consultant on the project, author Robert Valuck assisted in the translation of variables
into opioid equivalence units and provided direction on the pharmaceutical variable selection …